Synthetic biology is entering practical use across medicine, agriculture, industrial biomanufacturing, food systems and environmental applications. This transition creates biosafety and biosecurity challenges that technical safeguards or compliance rules alone cannot solve. The recent UNESCO International Bioethics Committee (IBC) report provides an important ethical perimeter for synthetic biology, but principles must be translated into research habits, institutional cultures and deployment practices. This Perspective proposes a dual-framework model: the UNESCO IBC report defines boundary conditions for responsible biological innovation, while the Humanity, Ethics, Creativity and Imagination (HECI) framework strengthens the human capacities needed to work responsibly within them. Drawing on agricultural education and policy reform in Uzbekistan as a proof-of-principle, the article argues that biosafety in synthetic biology requires not only safer rules, but also scientists, institutions and regulators capable of empathy, judgment, creativity and foresight. The model is intended to stimulate practical experiments in ethics-integrated curricula, design reviews, field-deployment checklists and locally adaptable governance.
No takes yet. Share an insight, caveat, or question.
Ibrokhim Yulchievich Abdurakhmonov (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: